Pharmaceutical Products

Browse Popular Categories

Blog / Pharmaceutical Products

Pharmaceutical Products
Blog, Sergey Avramenko, July 12, 2018 77

In 2016, EU vaccines for human medicine market was at 8.0 billion EUR, which was 831 million EUR (or 9%) less than the year before. There was a significant growth by 43% in 2015 due to price increase, after a fluctuations in market volume with an overall upward trend.

Pharmaceutical Products
Blog, Anna Sergeeva, June 26, 2018 57

In 2016, the antisera and other blood fractions market grew by 12% to 76 billion USD. From 2007 to 2016, the global value of consumption of antisera and other blood fractions almost doubled, which was due to the rising demand in developing countries. 

Pharmaceutical Products
Blog, Sergey Avramenko, May 28, 2018 21

In 2016, the global vitamin imports stood at 450K tonnes, lowering by -17.6% against the previous year figure. Overall, vitamin imports continue to indicate a relatively flat trend pattern. The growth pace was the most rapid in 2010, when import increased by 16% y-o-y. Over the period under review, global vitamin imports reached its maximum volume of 546K tonnes in 2015, falling back in the following year. In value terms, vitamin imports stood at $6.6B in 2016. The total import value increased at an average annual rate of +3.4% from 2007 to 2016; the trend pattern remained relatively stable, with somewhat noticeable fluctuations being recorded throughout the analyzed period. Over the period under review, global vitamin imports reached its maximum level of $7.2B in 2011; however, from 2012 to 2016, it failed to regain its strength. Top Vitamin Importing Countries in the World 1. Germany (499.8 million USD) 2. Netherlands (324.2 million USD) 3. France (313.7 million USD) 4. Singapore (266.6 million USD) 5. Belgium (251.5 million USD) 6. China (230.8 million USD) 7. Japan (199.6 million USD) 8. Canada (192.0 million USD) 9. Brazil (184.8 million USD) 10. United Kingdom (181.8 million USD) 11. Spain (176.5 million USD) 12. Indonesia (153.7 million USD) Vitamin Imports By Country The imports of the twelve major importers of vitamin, namely Germany, the Netherlands, Belgium, France, the UK, Japan, Brazil, Singapore, Indonesia, Canada, China, and Spain, represented more than half of total import. From 2007 to 2016, the most notable growth rate of vitamin imports, among the main importing countries, was attained by Indonesia (+8.1% per year), while the other global leaders experienced more modest paces of growth. In value terms, Germany ($500M), the Netherlands ($324M) and France ($314M) were the countries with the highest levels of imports in 2016, with a combined 17% share of global imports.Singapore, Belgium, China, Japan, Canada, Brazil, the UK, Spain and Indonesia lagged somewhat behind, together comprising a further 28%. Indonesia (+9.8% per year) recorded the highest rates of growth with regard to the vitamin imports, among the main importing countries, over the last 9 years, while the other global leaders experienced more modest paces of growth. Vitamin Import Prices By Country The average vitamin import price stood at $15 per kg in 2016, surging by 33% against the previous year. Over the period from 2007 to 2016 it increased at an average annual rate of +3.9%.The pace of growth appeared the most rapid in 2008, an increase of 53% year-to-year. In that year, average vitamin import price reached its maximum level of $16 per kg. From 2009 to 2016, growth of average vitamin import price stood at a somewhat lower level.

 
Pharmaceutical Products
Blog, Anna Sergeeva, May 28, 2018 23

In 2016, the global imports of antisera stood at 1.4M tonnes, moving up by 468% against the previous year figure. Overall, antisera imports continue to indicate an outstanding expansion. The most prominent rate of growth was recorded in 2016, when import increased by 468% from the previous year level.

Pharmaceutical Products
Blog, Sergey Avramenko, May 28, 2018 18

In 2016, the global antibiotic imports stood at 123K tonnes, reducing by -20.8% against the previous year level.

Pharmaceutical Products
Blog, Anna Sergeeva, May 28, 2018 19

In 2016, the amount of vitamin exported worldwide amounted to 424K tonnes, declining by -4.9% against the previous year level.

 
Pharmaceutical Products
Blog, Anna Sergeeva, May 28, 2018 18

In 2016, the amount of antisera exported worldwide totaled 226K tonnes, descending by -17.3% against the previous year level.

Pharmaceutical Products
Blog, Anna Sergeeva, May 28, 2018 18

In 2016, the global exports of antibiotic totaled 136K tonnes, shrinking by -8.0% against the previous year figure. In general, antibiotic exports continue to indicate a temperate descent. The pace of growth appeared the most rapid in 2010, when exports increased by 25% year-to-year. Global antibiotic export peaked of 267K tonnes in 2011; however, from 2012 to 2016, it stood at a somewhat lower level.

Pharmaceutical Products
Blog, Maria Fadeeva, November 03, 2016 844

From 2007 to 2015, global exports of antisera and other blood fractions showed steady growth, amounting to 93,254 million USD in 2015. There was an annual increase of +12.8% throughout the analyzed period.

 
Pharmaceutical Products
Blog, Maria Fadeeva, October 24, 2016 1022

The global trade in antibiotics amounted to 11,187 million USD in 2015, showing some fluctuations over the period under review. A slight decline in 2009 was followed by a peak in 2011, until exports decreased again. Overall, there was an annual decrease of -0.1% from 2007 to 2015.

Pharmaceutical Products
Blog, Anna Sergeeva, August 10, 2016 587

After a four-year period of a steady decline, total imports of provitamins and vitamins in the EU Member States surged rapidly, reaching 2,023 million EUR in 2015. Data concerning the EU trade with non-EU countries shows that the EU remains a net importer of provitamins and vitamins.

Pharmaceutical Products
Blog, Irina Andreeva, July 14, 2016 365

The U.S. ranks fourth globally in exports on the biological product market with a 12% share (based on USD), following Switzerland (21%), Germany (18%), and Belgium (13%). The U.S. exported 17,378 million USD in 2015, which was 20% over the previous year's value.

 
Pharmaceutical Products
Blog, Irina Andreeva, July 13, 2016 470

The U.S. is the global leader in the trade of in-vitro diagnostic substances, accounting for a 23% share (based on USD) of the world's exports. It was followed by Germany (19%), the UK (8%), and the Netherlands (8%).

Pharmaceutical Products
Blog, Olga Minchina, November 12, 2015 347

From 2007 to 2014, EU antibiotic production showed mixed dynamics, rising from 34.1 tonnes in 2007 to 68.1 tonnes in 2014. Over the period under review, it expanded with a CAGR of 10.4%. In value terms, EU antibiotic production decreased to 2.1 billion EUR in 2014, falling 9.0% annually.

Pharmaceutical Products
Blog, Olga Minchina, August 06, 2015 584

China is one of the largest global producers and consumers of antibiotics. In 2014, China exported 27.4% of its total antibiotics output. Of this amount, 23% was supplied to India, where Chinese antibiotics held a 28% share of total India's consumption.

 
Pharmaceutical Products
Blog, Olga Minchina, July 16, 2015 384

Switzerland seized control of the antisera and other blood fractions market. In 2014, Switzerland exported 5.8 thousand tonnes of antisera and other blood fractions totaling 25.7 billion USD, 8% over the previous year. Its primary trading partner was Germany, where it supplied 15.6% of its total antisera and other blood fractions exports in value terms, accounting for 24.2% of Germany's total imports.

Pharmaceutical Products
Blog, Alexander Romanenko, July 13, 2015 285

Switzerland is one of the leaders in the global antibiotics trade. However, in 2014, Switzerland exported 289.6 tonnes of antibiotics totaling 1.4 billion USD, a full 23% under the previous year. Its primary trading partner was Germany, where it supplied 46.3% of its total antibiotics exports in value terms, accounting for 77.7% of Germany's total imports.

Pharmaceutical Products
Blog, Alexander Romanenko, July 08, 2015 418

Belgium dominates in the global trade of vaccines for human medicine. In 2014, Belgium exported 6,199 tonnes of vaccines for human medicine totaling $10,526M, 39% over the previous year. Its primary trading partner was France, where it supplied 30.9% of its total vaccine for human medicine exports in value terms, accounting for 83.3% of total French imports.